Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy

Clinical trial NCT07423390 · RECRUITING

Trial details

NCT number: NCT07423390
Sponsor: Qinghai Red Cross Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Neuropathy Due to Chemotherapy Peripheral Neuropathy, Chemotherapy-induced

Start date: 2026-02-24
Primary completion: 2029-03-30
Enrollment: 326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.